03.02.26 -- Sites Are Driving Clinical Tech Evolution

The London Biotech Show 2026 is Europe’s leading platform for the biotechnology industry, showcasing the full spectrum of red biotech including biopharmaceuticals, therapeutics, gene and cell therapy, regenerative medicine, diagnostics, precision medicine, vaccines, clinical trials, and biomanufacturing. The event brings together biotech companies, pharmaceutical leaders, lab suppliers, medtech innovators, investors, researchers, policymakers, and solution providers from across the globe to exchange knowledge, forge partnerships, and accelerate innovation.

On December 15, 2025, the FDA finalized its guidance Enhancing Participation in Clinical Trials, formally updating expectations for enrollment and trial design. Here's what you can do now.

At SCOPE Summit 2026, Joe Dustin shared why clinical trial sites are emerging as the next drivers of innovation. As sites digitize operations and push back against the burden of sponsor-mandated systems, new models like “bring your own technology” and seamless digital data flow aim to reduce duplication, speed startup, and improve both coordinator and patient experiences.

City of Hope has embedded an internally trained AI platform into oncology care and research workflows, helping clinicians summarize complex patient histories and match patients to clinical trials in real time. By reducing manual review and accelerating feasibility assessments across its national network, the system is improving trial access, easing clinician workload, and shifting more time back to patient care.